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D-aspartate Receptors in a Rat Carotid Endarterectomy Model
Mohammed Moursi, Hongju Deng, John Nyalala. University of Arkansas
for Medical Sciences, Little Rock, Ark
Introduction: We previously demonstrated that N-methyl-D-aspartate
(NMDA) receptor exists in vascular smooth muscle and endothelial cells
and that homocysteine may act via the NMDA receptor to increase
neointimal hyperplasia. In the current study, we first investigated the
expression profile of the constituent NMDA receptor subunits after a
vascular surgical procedure in an environment of hyperhomocysteinemia
in a rat model; and second, we evaluated the expression of NR2D-
containing NMDA receptor at transcriptional and protein level after
vascular injury in a rat model.
Methods: Rats were fed a homocysteine-supplemented diet or a con-
trol diet for 2 weeks before carotid endarterectomy (CEA) and continued on
preoperative diets. Animals were euthanized at 3, 8, or 14 days postopera-
tively and carotid arteries were processed for molecular studies (quantitative
real-time reverse transcriptase polymerase chain reaction, Western blot) and
histomorphometry.
Results: All five known NMDA receptor subunits (NR1, NR2A-2D)
messenger (m)RNAs were expressed in carotid arteries of homocysteinemic
rats at 2 weeks after CEA, but at different levels. Receptor subunit NR2D
mRNA rose sixfold vs NR2A, fourfold vs NR2B or NR1, and three times vs
NR2C (P .05). Protein bands corresponding to NR1 and NR2A-2D also
showed immunoreactivity at 2 weeks after injury. The receptor subunit
NR2D protein band was prominently expressed in the carotid artery com-
pared with other subunits. This robust NR2D receptor subunit protein
expression in the postinjury carotid artery is mimicking the high level of
mRNA expression observed using polymerase chain reaction. Homocysteine
supplementation for 8 or 14 days, but not 3 days after CEA, triggered
significant upregulation of both NR2D mRNA and protein vs control CEA
(all P  .0004). Furthermore, rats fed the control diet for 8 or 14 days, but
not 3 days after CEA, revealed a remarkable increase in NR2D mRNA and
protein expressions vs control non-CEA (intact) arteries (all P  .019).
Although damage to the carotid artery appears to upregulate the expression
of the NR2D receptor subunit, there was a quantitative difference in
response to vascular injury alone vs injury supplemented with homocysteine
at 3, 8, or 14 days postoperatively, with the latter being higher. Neointimal
hyperplasia, expressed as percentage luminal stenosis of the carotid artery
was significantly increased in CEA plus homocysteine vs CEA on control
diets at 2 weeks (P  .0001).
Conclusions: This preliminary study is the first to show that mRNA
and protein for NR2D-containing NMDA receptor were upregulated in the
carotid artery at 8 or 14 days after CEA in a time-dependent manner, with or
without homocysteine supplementation. CEA with homocysteine supple-
mentation for 2 weeks triggered a significant increase in luminal stenosis.
This morphologic and biochemical evidence represents the basis for our
assumption that the NR2D receptor subunit may be involved in homo-
cysteine-mediated hyperplastic response. We suggest that the NR2D
Fig 2.receptor subunit may constitute a useful therapeutic target to prevent/
attenuate neointimal proliferation after vascular injury.
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mtherectomy Offers no Benefits Over Balloon Angioplasty in Tibial
nterventions for Critical Limb Ischemia
evin E. Todd, Jr, Christian A. Maurer, Johnathan A. Higgins, Jung H.
im, Sadaf S. Ahanchi, JeanM. Panneton. Eastern VirginiaMedical School,
orfolk, Va
Introduction: Endovascular adjuncts, like atherectomy, have been
eveloped in order to improve outcomes for patients undergoing endovas-
ular treatment for peripheral arterial disease (PAD). The true impact of
therectomy on endovascular outcomes remains to be determined, and no
ata exist on the influence of atherectomy on tibial interventions. Our study
ompares the early and late outcomes of tibial intervention with angioplasty
s atherectomy.
Methods: We completed a retrospective review of all tibial interven-
ions between 2008 and 2010. Preprocedural, procedural, and postproce-
ural data were collected using paper and electronic systems. Factors affect-
ng patient outcomes were analyzed using single and multivariate analysis,
ox regression analysis, and Kaplan-Meier life-table curves. Primary out-
omes were primary, primary assisted, and secondary patency rates, as well as
imb salvage and survival.
Results: After review, 480 tibial interventions were completed for 421
imbs, 418 (87%) presented with critical limb ischemia (CLI) and 62 (13%)
ith claudication. A total of 192 isolated tibial interventions were com-
leted, and 288 multisegment interventions were completed. The CLI
ohort of 418 limbs was selected for analysis. These patients were a mean age
f 71 years, with a mean follow-up time of 16  15 months (range, 0-59
onths). Moat patients (60%) were men, with predominant risk factors of
ypertension (92%), tobacco use (64%), diabetes (72%), hyperlipidemia
65%), and chronic kidney disease (39%). Of the 418 limbs, 339 underwent
ercutaneous transluminal angioplasty (PTA): 333 PTA alone and six
TAstent. The remaining 79 limbs received atherectomy (33 laser, 13
irectional, 33 orbital) alone or in conjunction with PTA (11 atherectomy
nly, 68 atherectomyPTA). The groups did not differ significantly in age,
ex, risk factors, occlusion vs stenosis, or technical success. The atherectomy
roup had significantly more TransAtlantic Inter-Society Consensus
TASC) B lesions (54% vs 38%, P  .013), and the PTA group had
ignificantly more TASC D lesions (25% vs 13%, P  .049). TASC A and C
esions did not differ significantly between the two groups. No significant
ifferences existed with respect to the early (30-day) outcomes of loss of
atency (11% vs 13%, P .70), complications (9% vs 13%, P .41), or major
mputation (17% vs 13%, P  .34). Furthermore, there was no difference
etween treatment groups in symptomatic relief at first follow-up (61% vs
5%, P  .53) or Rutherford score improvement (70% vs 69%, P  .81).
aplan-Meier analysis revealed no difference in primary outcomes of PTA vs
therectomy at the 12-month and 36-month assessments: primary patency
69% and 55% vs 61% and 46%, P .15), primary assisted patency (83% and
1% vs 85% and 67%, P .80), secondary patency (94% and 89% vs 95% and
9%, P  .89), limb salvage (79% and 70% vs 81% and 77%, P  .49), or
urvival (77% and 56% vs 80% and 50%).
Conclusions: The adjunctive use of atherectomy offered no improve-
ent over PTA in early or late outcomes in patients with CLI who under-
ent endovascular tibial interventions. Considering the additional cost and
ncreased procedural time, these findings put into question the routine use of
djunctive atherectomy.
rospective, Multicenter Analysis of Perioperative Patency for Tibial
ypass: Comparison Among Different Conduit Configurations
ao-Ngoc H. Nguyen, Richard F. Neville, Richard Amdur, Mustafa Abugi-
eiri, Anton Sidawy. George Washington University, Washington, DC
Introduction: Despite advances in endovascular techniques, tibial
ypass may still be required for revascularization to obtain healing and limb
alvage. Perioperative (30-day) graft patency is an important outcome
arameter reflecting technical considerations and acute graft thrombosis.
oth are important prerequisites for long-term patency. In this analysis, the
0-day patency of the great saphenous vein (GSV) is compared with alter-
ative conduit configurations for tibial bypasses.
Methods: The study cohort consisted of all primary tibial bypasses
ntered in a prospective, multicenter database (American College of Sur-
eons-National Surgical Quality Improvement Program) from 2006 to
010 with exclusion of reoperative cases. The bypasses were divided into six
roups: (1) GSV, (2) prosthetic conduit, (3) prosthetic conduit with a distal
nastomotic venous adjunct, such as a cuff or patch, (4) composite graft of
xpanded polytetrafluoroethylene and a vein segment, (5) spliced autoge-
ous vein, and (6) arm vein. Thirty-day graft failure, patient demographics,
nd operative details were compared among groups. Univariate associations
etween patient factors and conduit were tested, and those variables that had
 .20 were used in a multivariate model to predict patency.
Results:A total of 5375 tibial bypasses were analyzed by conduit: GSV,
983 (74%); prosthetic, 889 (17%); spliced vein, 160 (3%); prosthetic with
djunct, 112 (2%); arm vein, 93 (2%); and composite, 91 (2%). There was no
ifference among groups in terms of diabetes, renal failure, tobacco use, or
est pain as an indication for bypass. There was no difference in perioperative
ortality based on conduit. After adjusting for gender, age, weight, race,
